Market Cap

Fulgent Genetics, Inc. Market Capitalization:

$791.0 Million

USD as of Jan. 1, 2026

business Fulgent Genetics, Inc. Company Profile

Fulgent Genetics, Inc. Main Stock Listing

NASDAQ: FLGT

Market Capitalization History of Fulgent Genetics, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $222.61 B
Danaher $164.98 B
Siemens Healthineers AG $57.84 B
IDEXX Laboratories, Inc. $53.62 B
Lonza Group Ltd $47.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Fulgent Genetics, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $791.0 M 50.28%
Jan. 1, 2025 $526.4 M -36.96%
Jan. 1, 2024 $835.1 M -15.33%
Jan. 1, 2023 $986.2 M -48.91%
Jan. 1, 2022 $1.93 B -42.19%
Jan. 1, 2021 $3.34 B 725.78%
Jan. 1, 2020 $404.4 M 236.18%
Jan. 1, 2019 $120.3 M -10.96%
Jan. 1, 2018 $135.1 M -65.80%
Jan. 1, 2017 $395.0 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Fulgent Genetics, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Fulgent Genetics, Inc. has the following listings and related stock indices.


Stock: NASDAQ: FLGT

Stock: BMV: FLGT

Stock: FSX: 7F0

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.